Downloads provided by UsageCounts
Data from the drug interaction studies reported in the drug approval package for Epidiolex (cannabidil), U.S. Food and Drug Administration: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000TOC.cfm. The data was manually extracted by a trained pharmacist from the PDF documents uploaded to drugs@fda for Epidolex drug approval package. The data extraction was reviewed for quality by an expert in pharamacology and natural product-drug interactions.
{"references": ["Drug approval package for Epidiolex (cannabidil), U.S. Food and Drug Administration: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000TOC.cfm"]}
The data extraction was done with grant support from United States National Institutes of Health grant U54AT008909 from the National Center for Complementary and Integrative Health.
drug approval package, natural product-drug interactions
drug approval package, natural product-drug interactions
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 15 | |
| downloads | 9 |

Views provided by UsageCounts
Downloads provided by UsageCounts